Acquisition proposals typically lead to an increase in the stock price of the target company due to the potential for a buyout at a premium. Since Theseus Pharmaceuticals is directly involved and is the target of the acquisition interest, this news is highly relevant and important to its investors. The confidence score is not at the maximum because the company is still evaluating the offer, and the outcome is uncertain.